Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2N09

NMR structure of a short hydrophobic 11mer peptide in DMSO-d6/H2O (1:3) solution

2N09 の概要
エントリーDOI10.2210/pdb2n09/pdb
関連するPDBエントリー2N08 2N0I 2N0N
NMR情報BMRB: 26536
分子名称Short hydrophobic peptide with cyclic constraints (1 entity in total)
機能のキーワードhydrophobic peptide, glp-1r agonist, de novo protein
タンパク質・核酸の鎖数1
化学式量合計1271.34
構造登録者
主引用文献Hoang, H.N.,Song, K.,Hill, T.A.,Derksen, D.R.,Edmonds, D.J.,Kok, W.M.,Limberakis, C.,Liras, S.,Loria, P.M.,Mascitti, V.,Mathiowetz, A.M.,Mitchell, J.M.,Piotrowski, D.W.,Price, D.A.,Stanton, R.V.,Suen, J.Y.,Withka, J.M.,Griffith, D.A.,Fairlie, D.P.
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists.
J.Med.Chem., 58:4080-4085, 2015
Cited by
PubMed Abstract: Cyclic constraints are incorporated into an 11-residue analogue of the N-terminus of glucagon-like peptide-1 (GLP-1) to investigate effects of structure on agonist activity. Cyclization through linking side chains of residues 2 and 5 or 5 and 9 produced agonists at nM concentrations in a cAMP assay. 2D NMR and CD spectra revealed an N-terminal β-turn and a C-terminal helix that differentially influenced affinity and agonist potency. These structures can inform development of small molecule agonists of the GLP-1 receptor to treat type 2 diabetes.
PubMed: 25839426
DOI: 10.1021/acs.jmedchem.5b00166
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 2n09
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon